• Lexaria Bioscience is a drug delivery technology innovator whose flagship technology, DehydraTECH(TM), provides a means of enhancing substances’ delivery time to increase their effectiveness without adverse effects
• A new podcast by NetworkNewsAudio highlights DehydraTECH’s successes in trials that measure blood pressure reduction using DehydraTECH-enhanced CBD in comparison with generic controls
• The DehydraTECH technology is also being analyzed for effectiveness in combatting inflammatory conditions, viral illnesses and alternatives to the lung-harming effects of smoking
• The company’s most recent filing with the SEC notes that its revenues more than doubled between May 2020 and May 2021, driven largely by product sales and licensing agreements

A new podcast highlights the effectiveness enhancement efforts by technology innovator Lexaria Bioscience (NASDAQ: LEXX) for treating high blood pressure (hypertension), a key risk factor for both heart disease and stroke that is common in the world’s adult populations, including in the United States. The podcast (https://ibn.fm/LIgxT) reviews many important entrepreneurial tips to business owners from Lexaria CEO Chris Bunka. It also notes that nearly half of all Americans have high blood pressure but only about 24 percent of those afflicted with it — many of whom are younger than 40. One of the most insidious aspects of high blood pressure is that, like diabetes, the damage they can cause is often already done by the time they are diagnosed, a reason India’s government recently announced that the health department has begun screening government employees for the conditions in all departments, for example (https://ibn.fm/vvFYi). Lexaria’s patented DehydraTECH(TM) technology is designed to enhance substances such as pharmaceutical drugs into a more readily bioavailable form that speeds up their time to effective use. Clinical trials have been analyzing its ability to accomplish this transformation without causing changes that adversely interfere with the drugs’ intended use, such as by inadvertently creating new molecular entities NMEs that would require more complex new regulatory approvals (https://ibn.fm/TLcLX). “Just last month, Lexaria announced that a human clinical study using DehydraTECH technology demonstrated a rapid and sustained drop in blood pressure along with excellent tolerability,” the podcast states. “Initial results show that blood pressure was reduced across both male and female volunteers and was most pronounced in the first 10–50 minutes of the study treatment, reinforcing pre-existing findings demonstrating that DehydraTECH delivers superior performance over generic controls.” The company’s focus on DehydraTECH is not only to produce a better solution for delivering blood pressure treatments, but also anti-virals that battle SARS-CoV-2/COVID-19, HIV and other illness-causing invaders. DehydraTECH is also being looked at as a way of making nicotine orally ingestible at a level of quick absorption and efficacy superior to smoked and vaped drugs with the intent of creating a desirable and less harmful alternative to lung-harming inhalation of the substances (https://ibn.fm/COLsW). Last month Lexaria chose to delist its common shares from the Canadian Securities Exchange in order to focus on trading on the Nasdaq Capital Markets (Nasdaq ticker LEXX), where it has been seeing greater liquidity and can reduce the fees and managerial commitment that went into a dual listing (https://ibn.fm/CaOFZ). The company’s July 10-Q filing with the Securities and Exchange Commission noted that revenues more than doubled between May 2020 and May 2021, driven by intermediate product sales of DehydraTECH-enabled powders that companies can purchase to include in their products and licensing fees arising from definitive agreements for the DehydraTECH technology (https://ibn.fm/krv09). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Avricore recently launched HealthTab, its point-of-care testing platform, in 12 Shoppers Drug Mart stores as well as in several independent pharmacies in Canada
• Speaking in a recent PBA à Noon podcast, Avricore CEO Hector Bremner outlined several benefits and capabilities of the platform
• HealthTab processes patients’ diagnostics and biometric data to generate easy-to-read personalized reports that patients and professionals can use to guide care plans
• It can also power third-party health tech products with real-world results and diagnostics as it is built on an open API platform

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is disrupting and revolutionizing the pharmacy practice through its proprietary solution that combines various novel elements and enables users to enjoy a plethora of benefits at a lower cost. This was part of the message company CEO Hector Bremner delivered during a recent PBA à Noon podcast episode hosted by Paul Benwell & Associates (https://ibn.fm/B4x3F). Bremner was describing Avricore’s point-of-care testing platform, HealthTab(TM), which was recently launched in 15 Shoppers Drug Mart stores located in the Greater Toronto Area and in several independent pharmacies in British Columbia and Ontario (https://ibn.fm/aSKLh). “HealthTab sources the best point-of-care analyzers and brings them onto a single, secure cloud-based network. It gives patients and pharmacies access to results on the spot and makes de-identified data available in real-time. This harmonized model for community-based testing is the first of its kind, making Avricore the clear leader in this rapidly emerging space,” reads the company’s presentation (https://ibn.fm/8RwEG). In describing exactly what HealthTab is, Bremner delineated the platform’s functionality. Everything begins when the patient provides consent and answers a customized health survey when creating an account, either online or within the store. While at the store, the integrated on-site lab-accurate testing device collects the patient’s diagnostics information. The HealthTab system then merges the data from the survey and testing device, processes it using complex calculations to filter the biometric and diagnostic data of the patient, and then generates personalized reports. “And so, the power of HealthTab is that it is able to greatly reduce the amount of administration time, extract the result directly out of the machine, merge information, do the complex calculations in order to properly interpret the data, and then produce it in an easy to read format that the patient and professional can interpret quickly and understand the result and then use that to guide their care plan,” Bremner continued. In addition to these benefits and capabilities, HealthTab boasts a de-identified real-time data attribute that can enable researchers, drug makers, governments, and NGOs to use the platform to conduct studies and research in real-time, real-world settings in community pharmacies. Although de-identification, while desirable, is not a new concept, it is done on an ad hoc basis, according to Bremner. “It’s been largely due to lack of infrastructure and the type and costing of that type of testing that has been available to them in the pharmacy,” explained Bremner. “However, HealthTab is the breakthrough. We’ve simplified it, made it easy, and affordable.” Built on an open API platform, HealthTab can connect to other B2B or B2C health data-focused software. As a result, the platform, which supports easy and quick data transfers, can power third-party health tech products with real-world results and direct diagnostics from pharmacies. HealthTab also has a “fantastic interface” that allows individual patients to seamlessly navigate the platform. Through the various features packed into HealthTab, Avricore is empowering patients along a healthier path. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• Since its inception, Friendable’s flagship offering, Fan Pass, has seen thousands of artists sign up on the platform and take advantage of additional perks available
• The company’s 120-day plan has included upgrades to the UI/UX experience, rebranding, and new apps, which are available to download in both the Google Play and Apple Stores
• Last week, Friendable unveiled new artist and fan video trailers as the company prepares its digital marketing campaign for kickoff

The Fan Pass streaming artist platform, the flagship offering of mobile technology and marketing company Friendable (OTC: FDBL), offers artists various revenue streams by giving them a virtual stage where they can earn on live event ticket sales, merchandise sales, and artist contests. The platform has seen thousands of artist sign-ups since its birth in July 2020, and recently, an all-new app has been approved and made available for download by Google Play and Apple Stores for Android and iOS-based devices. Continuing with the company’s 120-day plan, Friendable has accomplished several milestones, including releasing the new Fan Pass user app and UI/UX experience to the app stores on its one-year anniversary. Earlier this month, Friendable announced its corporate rebranding to maximize the company’s visibility and market position of the Fan Pass platform. The rebranding sets the foundation for Friendable’s next phase of growth which was kicked off by the new app and website experiences for artists and fans. When discussing Friendable and Fan Pass’ year, Friendable’s CEO Robert A. Rositano, Jr. talked about how growth had been one of the primary focuses. The success of that campaign has led to faster-than-expected growth in terms of the number of users signing up (https://ibn.fm/hNRpK). “We quickly moved to accomplish two ancillary goals: 1. Support the platform through cohesive message, business model, and strategy; 2. Adjust the development of version 2.0 to deliver a superior platform to artists and fans,” Rositano explained. “Now, clearly communicating who we are and what we do is hugely important as we focus on building a big business in this rapidly growing marketplace and prepare to ramp-up advertising efforts for both artist and fan acquisitions.” Having begun with the platform’s upgrade to 2.0, the focus has now been shifted to the company’s digital media assets. Most recently, Friendable released two new video trailers designed to showcase the Fan Pass platform and entice both artists and music fans worldwide, prompting an increase in sign-ups (https://ibn.fm/M8h2x). Ultimately, Rositano hopes that the trailers will help encourage fans and artists into taking advantage of the seven-day free trial – a conversion metric they plan on watching intently. The Fan Pass platform is unlike any other, offering a place where artists can showcase their talent and content, while their fans come together in one place to support the music they love. The Fan Pass “VIP All Access” experience provides fans with:

• Access to live performances and online concerts
• Backstage meetups with artists – before, during, and after the show
• Livestreams and studio sessions
• Behind-the-scenes footage of music video and photoshoots
• Special interviews and one-on-one videos
• Streams that highlight the artists’ daily lives

The experience is available to fans at a subscription price, paid monthly or purchased annually. Fan Pass is free for artists to sign-up and offers paid specialty services, including merch designs, marketing materials, and artist/band logo design opportunities. The pricing for these services starts at $45. Friendable also signed a Letter of Intent (“LOI”) with Santo Blockchain Labs and Santo Mining Corp. (OTC: SANP) to develop global entertainment and musical artist-driven non-fungible tokens (“NFTs”). NFTs are a unit of data stored on a digital ledger (blockchain) that certifies the asset is unique and not interchangeable. The company believes that NFTs will provide an additional revenue stream for the artists, Friendable, and Santo Blockchain. For more information, visit the company’s website at www.Friendable.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

Date: September 13-15, 2021 Venue-The Marriott Marquis Times Square, New York- Virtual only access also available Businesses, financial institutions, fintech industry leaders, and financial wizards are invited to attend the FinovateFall Conference being held on September 13-15, 2021, at The Marriott Marquis Times Square, New York. This 3-day event will showcase innovative demos, live streaming sessions from reputed speakers, and be attended by influential thinkers from across the globe. FinovateFall is the center stage of the Fintech world offering connections and ideas you need are to grow and excel in your business. Even though 2020 is behind us, the scare of the Covid pandemic has altered the financial sphere forever.  In the present scenario, the world needs fintech now more than ever. Whether you’re a fintech or a financial institution, this FinovateFall event is for you. At this Fintech conference, witness cutting-edge fintech demos, get insights from the industry stalwarts, share your views and discuss the future of Fintech with peers and visionaries. Connect digitally or join us in person! Finovate is a global platform that connects start-ups, tech companies, financial enterprises, regulators, and investors across the globe. A webinar that adds value to your enterprise, participants can be a part of live discussions, meetings, live demos from startups and established companies, and opinions of experienced fintech professionals. The event will showcase 50+ demos of financial technology along with innovations in customer experience, reg tech, insurtech, prop tech, health tech, wealth tech, security, identity, biometrics, blockchain, crypto, investment, onboarding, open banking, digital banking, lending, payments, and more, on the main stage. This global event will feature 90+ innovative speakers sharing their valuable views on the latest updates and discoveries in the Fintech sphere. Learn the latest trends of the business finance world and innovative strategies that will help you take your enterprise forward. The event features 50% attendees from financial institutions, 20 top US banks, and 275+ representations from financial institutions. Reasons to attend:

• Connect face-to-face or digitally with the fintech industry professionals and influencers
• Get a fresh perspective on the latest fintech trends
• Connect with other businesses and avail the vast networking opportunities
• Seek the biggest opportunities in the market, before your competitor grasps the opportunity
• Get maximum value out of your session with the experts, influencers, analysts, and innovators

To know more details about the event and the discounts available, please visit https://informaconnect.com/finovatefall/.

Date: August 30-31, 2021 Online Livestream Pharmaceutical, biotech, and medical device professionals/employees are invited to attend DGE’s Pharma Employee Engagement & Experience Summit on August 30-31, 2021. The Summit will concentrate on core areas to cultivate positives, maintain trust, and prioritize equity to achieve a safe, productive workforce experience. The conference will address the most vital employee engagement concerns, guided by valuable inputs from pharma leaders and thinkers who will share their insights and opinions in the 2-day event. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The world-class event company is an industry leader meeting the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. When employees are committed to their work and organization, businesses will derive the maximum workforce productivity – this factor is now more critical than ever before as employees are working in remote and hybrid environments. An employee who is disengaged will not fulfil his responsibilities duly, this hold especially for life science organizations where people work under diverse leaders and work environments. The conference will feature reputed speakers and dignitaries of the life science industry associated with Human resources and employee engagement. As the global pandemic has changed the way we work, the work nature of pharma employees is undergoing a huge evolution. Many uncertainties and challenges will pose threats to employee engagement. The HR leaders at the conference will discuss numerous strategies to increase employee engagement for remote and hybrid workforces. The main agenda of the conference includes the following:

• Detailed strategies to create diverse workplaces under diverse leadership
• Important initiatives to support employees’ wellness and create a better work-life balance
• Discuss and understand the factors that impact the recruitment function in the post-COVID world
• Key techniques to engage employees and develop great leaders for life science organisations
• Strategies essential to create positive workplace cultures that foster employee connection and increase engagement
• Insights on how organizations are creating a new “normal” and conducive work environment for employees
• A roadmap for building an engaged and connected remote and hybrid workforce

The main focus of the event is to ensure the growth of professionals and their engagement with their respective life science organizations which is important for the company leadership and success. For tickets to the event, please visit https://ibn.fm/jwNdo

• One year after the deadline for submitting Premarket Tobacco Product Applications, the FDA is targeting September 9, 2021 for an announcement on which products will be allowed for sale
• Kaival is the exclusive global distributor for products made by BIDI Vapor, which has seen its PMTAs pass two out of three phases in the FDA process
• Kaival competition was recently thinned considerably when the FDA rejected approximately 4.5 million of the 6.5 million PMTAs received

Despite efforts by the U.S. Food and Drug Administration in recent years to implement and enforce new regulation governing e-cigarette market, illegal goods and practices still abound. The days of illicit nicotine products may be dwindling down, representing a paradigm shift supported by companies like Kaival Brands Innovations Group (NASDAQ: KAVL) that are deeply committed to seeing only safe, 21-years and older use of vape products. Kaival, the exclusive global distributor of a portfolio of premium vape products manufactured by BIDI Vapor, LLC. Last year, the FDA set September 9, 2020 as the deadline for companies to submit Premarket Tobacco Product Applications (“PMTA”) seeking authorization to market specific tobacco products. The long-and-short of new regulations is that there are only three ways to legally sell a tobacco product: one: a product can be grandfathered in by having been on the market before February 15, 2007; two: a brand can receive FDA approval to a Substance Equivalence application deeming a product similar to a grandfathered in product; and three,  through submission of a PMTA, which identifies the product as introduced to the market after February 15, 2007 and unlike any grandfathered in. A company was required to submit a PMTA for every product it wishes to sell, including a separate PMTA for every different e-liquid flavor and device. This is the pathway for BIDI Vapor and its BIDI Stick electronic nicotine delivery systems (“ENDS”) product lineup that come in 11 different flavors. BIDI’s PMTAs have passed the first two phases: receiving an acceptance letter from the FDA for the PMTA and subsequently receiving a filing letter indicating the application has met the FDA’s baseline criteria, allowing it to move into the final phase. The “substantive” phase involves the FDA’s scientific review of the PMTA (https://ibn.fm/WI59h) and associated data. BIDI and Kaival are waiting for a final decision in the coming weeks, with an approval officially designating the products as “appropriate for the protection of public health.” The FDA received over 6.5 million PMTAs from over 500 countries by the deadline which are now under review, with a target completion date of September 9, 2021. The list was trimmed by over 70% on August 9, 2021 when the FDA issued a Refuse to File (“RTF”) letter to JD Nova Group LLC, the owner of Vapolocity (https://ibn.fm/Zy8o9). The RTF stated that the applications for approximately 4.5 million JD Nova products “lacked an adequate Environmental Assessment,” meaning that they will have to be removed from the market or risk enforcement action by FDA. The RTF effectively dismissed 75% of the new products looking to make it to market. Kaival and BIDI, with their industry-leading regulatory and youth access prevention practices, continue to be relentless advocates for increased regulatory oversite to ensure e-cigarette products do not reach the hands of consumers under 21 years old, and are recycled, when possible, through their BIDI cares program. As the major FDA PMTA announcement approaches, some unethical companies are dumping their product into the markets before the crackdown and stiffer law enforcement begins. Ultimately, the announcement will determine which companies can remain on the market in a bit of a cleansing to weed out the industry’s bad actors for the good of public safety. “We place enormous importance on our integrity and our brand name,” said Nirajkumar “Raj” Patel, Founder and Chief Executive Officer of Kaival Brands. Patel, which also owns and controls BIDI Vapor, added, “not only are we ready for increased regulation and enforcement, we both encourage and welcome it.” For more information, visit the company’s website at www.KaivalBrands.com. NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

• Forbes article reports that the “business of music” becomes challenging for artists when they are unable to perform
• VR concerts are potentially much more lucrative than online pay-per-view concerts
• GTVH’s five-year agreement with Positron places the company in a strong position in the VR event space

The business of making music — and a living — became very complicated for artists during COVID-19. Most musicians make the bulk of their living through live performances and appearances, an impossibility during the global pandemic. Online pay-per-view performances became an option, but Golden Triangle Ventures (OTC: GTVH) believes the real promise is in virtual reality (“VR”) concerts; consequently, the company recently entered an exclusive partnership with Positron to develop a revolutionary immersive platform for VR concerts and events (https://ibn.fm/D8hTI). “In 2019, the top artists on Billboard’s Money Makers list earned between 75–90% of their yearly income from live performances and appearances,” a recent Forbes article reported (https://ibn.fm/qziVA). “When deprived of the ability to perform live, the business of music becomes much more challenging for many artists. Some have attempted to offset losses by performing online pay-per-view concerts, in which viewers pay a fee to watch an artist or band (either together or in separate locations) perform live music streamed at a specific time through a digital platform on various online and mobile devices.” In fact, according to the article, an estimated 60,905 livestreams took place between March 25 and December 12, 2020; streams with 10,000 or fewer “trackers” accounted for 46,000 (roughly 75%) of the livestreams, streams with between 10,001–250,000 trackers accounted for 19.1%, and major artist streams with 250,000 or more trackers accounted for 3.9%. “While there seems to be a viable audience for online pay-per-view concerts, it remains uncertain whether and to what extent fans are willing to pay a fee (or ticket price) to view them,” the article continued. “Virtual reality concerts, although less common than online pay-per-view concerts, are potentially much more lucrative.” Golden Triangle Ventures agrees. GTVH’s five-year agreement with Positron, a leading VR technology and entertainment company, places the company in a strong position in the VR event space. Positron’s platform, developed with Golden Triangle Ventures for its entertainment division under Lavish Entertainment, has the ability to elevate live concerts to the next level by offering more freedom to audiences to join remotely on VR headsets, AR-enabled mobile devices and 2D streaming devices. “This amazing new platform will enable us to monetize our events globally and license this technology to other event promoters around the world to accomplish the same goal,” said Golden Triangle Ventures CEO Steffan Dalsgaard. “Imagine entering a virtual venue with a group of your friends, having the ability to watch our live events while also watching your friends dance, and having the ability to experience live performance in real time through an augmented reality that we can customize and create for the specific events we organize. This platform is unlike anything we have seen, and we are so excited to partner exclusively with one of the most reputable VR companies in the space: Positron.” Golden Triangle Ventures noted that concerts and events hosted by Lavish Entertainment will also be available on Positron’s award-winning Voyager(R) VR motion pods, yet another new content category for location-based entertainment. Through this exclusive platform, performing artists can offer customized interactive 3D visualizations and worlds, available at both the live venue and inside the VR platform. “This will allow audiences to simultaneously view the live 360 stream of the artist and navigate into the virtual 3D world designed by the artist or creator,” the company stated. “Complementing this, audiences will be able to buy and share tickets to events, purchase digital merchandise including NFTs, as well as access an array of content the company will be providing.” Golden Triangle Ventures is a multifaceted consulting company with many projects being developed that provide synergistic values in the health, entertainment and technology industries. The company aims to purchase, acquire and/or joint-venture with established entities that management can help assist and develop into unique opportunities. For more information, visit the company’s website at www.GoldenTriangleInc.com. NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

• FuelPositive commissioned emissions reduction and carbon credit specialist, Andre Mech, to analyze Canada’s green off-peak electricity capacity and to determine the fuel needs and carbon emissions of the Canadian transportation sector
• The study revealed that Canada generates enough green electricity during off-peak hours to produce carbon-free NH3 that can power 100% of the needs of passenger aviation, bus, and rail and freight aviation, rail, trucks, and marine shipping
• Such an undertaking would reduce Canada’s total greenhouse gas emissions by 15.3%
• The analysis showed the opportunities and needs in Canada, meaning that the market for green ammonia exists

Our Planet, a 2019 nature documentary available on both Netflix and YouTube, perhaps provides the clearest and most relatable visual account of the effects of climate change on various creatures living in different environments around the world. From record-breaking ice melts in the Arctic and Antarctica, which scientists have warned are the clearest sign yet of an imminent climate change catastrophe, to drier-than-normal conditions in desert environments, the documentary illuminates multiple concerns. All these changes result from using fossil fuels, which, by virtue of supplying approximately 80% of the world’s energy, are the primary contributors to climate change and global warming. This means that to deal with the issue, replacing fossil fuels with renewable sources, alongside increasing energy efficiency and electrifying transportation, should be a priority (https://ibn.fm/mEUZU). Against this backdrop, scientists and activists alike have incessantly held that humanity needs to embrace the proposed solutions, in effect addressing the underlying causes of climate change. Guided by the need to replace fossil fuels with sustainable, clean energy, Toronto, Canada-based FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is doing its part. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (“NH3”), for use across a broad spectrum of industries and applications. Notably, NH3 is positioned as a viable alternative to fossil fuels. FuelPositive has already developed its flagship carbon-free NH3 technology that allows for the sustainable in-situ production of carbon-free NH3, using only air, water, and green electricity. With the build-out of mobile and scalable demonstration systems for the proprietary technology as part of its Phase II project having commenced in Q2 2021, FuelPositive has gone a step further, as detailed by a recent press release (https://ibn.fm/i9mGK). The company announced August 17 the findings of a study it had commissioned in early 2021. The study had Andre Mech, an emissions reduction and carbon credit specialist, analyze Canada’s green off-peak electricity capacity and determine the fuel needs and carbon emissions of the Canadian transportation sector, to establish whether it would be possible to replace fossil fuels used for transportation with carbon-free NH3. The study would also measure the impact the replacement would have on the country’s carbon emissions. The findings of the analysis were startling. Canada generates sufficient green electricity today (hydroelectricity, solar, and wind) during off-peak demand hours to produce enough carbon-free NH3 to power 100% of the needs of passenger aviation, bus, and rail and freight aviation, rail, trucks, and marine transport. Importantly, all these are regulated industries with notoriously high emissions and significant government mandates to decarbonize. The impact of such an undertaking on Canada’s total greenhouse gas emissions, of which CO2 emissions totaled 715.8 megatons in 2019, would be a 15.3% reduction. Additionally, the study revealed that the country produces enough off-peak green electricity to provide carbon-free NH3 fuel that can power 63% of all the passenger cars, aviation, and buses; light trucks and rail; motorcycles; freight trucks, aviation, and rail; and other sector vehicles in Canada. Further, Manitoba, Quebec, and Newfoundland & Labrador can cover their transportation requirements with carbon-free NH3 fuel produced using their own off-peak, green power. “Interestingly, the analysis also points out that the three provinces can also store their excess renewable electricity for later use, by running FuelPositive’s commercial modular and scalable carbon-free NH3 production systems on site,” reads the report (https://ibn.fm/SuMG8). “Switching from fossil fuels to carbon-free ammonia offers a viable, economical transition strategy for Canada’s transportation sector as we adopt new practices to address climate change,” said FuelPositive CEO Ian Clifford. According to the study’s author, Andre Mech, the analysis outlines the opportunities and needs at the provincial and national levels, which shows that suppliers and consumers exist. That, he notes, tells us that there is a market for green ammonia within Canada itself. Additionally, according to a July 5 report, the market for green ammonia exists globally and is projected to grow at a year-over-year rate of 54% from 2020 to 2025 (https://ibn.fm/QQ0Sf). For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• “I’m looking forward to being a key player in [The Alkaline Water Company’s] continued success,” says O’Neal
• WTER’s Alkaline88(R) continues to be one of the most prominent growing premium functional waters in the category
• Investors believe that Alkaline88 is becoming a household name for premium waters and a go-to brand across America

After initially joining The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) as an equity partner, board member and marquee brand ambassador for Alkaline88(R), basketball Hall of Famer and entertainment icon Shaquille O’Neal has invested an additional of $1.05 million in the alkaline water company. O’Neal and WTER chairman Aaron Keay made an equal investment in the company (https://ibn.fm/P2PvM). “I only invest in companies I believe in and products that I use,” said O’Neal. “Alkaline88 checks both boxes. We’ve got big plans for this company, and I’m looking forward to being a key player in its continued success.” The company noted that O’Neal and Keay’s investments accounted for more than 40% of the entire nonbrokered private placement, which comprised 4,757,381 subscription receipts sold at $1.05 per receipt; the gross proceeds of the private placement totaled $4,995,250.05. According to the announcement, WTER anticipates using the proceeds to expand production capacity and for use as general working capital. “Alkaline88 continues to be one of the most prominent growing premium functional waters in the category,” state Keay. “Having just reported another record year, the company could not be better positioned for aggressive growth throughout fiscal 2022 in multiple different sales channels. Leading this financing alongside Shaquille is not only an honor but an aligned testament to both our beliefs that Alkaline88 is becoming a household name for premium waters and a go-to brand across America.” WTER president and CEO Ricky Wright noted that the company could not have found a better partner for Alkaline88 than O’Neal. “I can’t overstate how business-minded he is about the success of this company, and I believe that this investment emphasizes that point even more,” said Wright. “We’re absolutely thrilled to have him as the face of our company, but even more so to count him as a business partner.” Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88, is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. Recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique all-natural flavors, with new flavors coming soon. For more information, visit the company’s websites at www.TheAlkalineWaterCo.com and www.a88CBD.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

• The company has officially filed to change its name to BlockQuarry Corp.
• ISW has focused on creating a building model concentrated in the digital mining sector
• Name change reflects corporate rebranding effort that reflects commitment to blockchain infrastructure, cryptocurrency mining and collaborative hosting

ISW Holdings (OTC: ISWH), global brand management holdings company with commercial operations in t renewable energy cryptocurrency mining, has announced plans for a major corporate rebranding, including a name change (https://ibn.fm/t9f0g). The company has officially filed to change its name to BlockQuarry Corp. “We have reached significant milestones in acquiring and commercializing blockchain and cryptocurrency data mining equipment and platforms over the past year,” said president and chair Alonzo Pierce. “As a result, we are rebranding to ensure our image better aligns with our ongoing operations and long-term strategic goals.” In addition to the name change, the rebranding will include a new interactive website BlockQuarry.io — which will launch in the coming weeks. Pierce noted that over the past year the company has focused on creating a building model concentrated in the digital mining sector. As a result, ISW has implemented additional investments in land and power expansions in Georgia following the launch of its Pennsylvania POD5 mining field. “The name change reflects a corporate rebranding effort necessitated by this demonstrable commitment to blockchain infrastructure, cryptocurrency mining and collaborative hosting,” the announcement noted. “We gravitated toward BlockQuarry because it is clearly and unambiguously tethered to the blockchain and cryptocurrency marketplace theme, and it carries an interesting dual meaning,” added Pierce. “As a noun, it refers to a place where blocks are extracted from the blockchain by the processing of encrypted algorithms. As a verb, it refers to the act of mining and extracting blockchain algorithms to produce a return in the form of coins. “Our deliberate investments and partnerships in the cryptocurrency space demonstrate our dedication to this new asset class as well as our well-defined path to becoming one of the most robust hosting and mining operators in North America,” Pierce conclude. “For all of these reasons, BlockQuarry best represents the mission and strategy we are implementing as we strive to maximize our return on shareholder capital. ISW/BlockQuarry Corp is quickly becoming one of the largest mining and hosting providers in the digital currency space in North America, as the company seeks to transform the financial markets of the future. The company’s complement of cutting-edge technologies has enhanced the bitcoin/cryptocurrency ecosystem, enabling its customers to take advantage of real-time cost savings. At the same time, the company’s customers can feel confident that their digital transactions and assets are entirely secure. ISW utilizes a scalable blockchain infrastructure to convert unique identifiable assets (“UIAs”) into interchangeable digital assets such as Bitcoin and other fungible digital assets. The company offers immediate liquidity in the form of fast, confidential transactions, as well as the issuance of assets in the traditional capital markets. For more information, visit the company’s website at www.ISWHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH